Vera Therapeutics, Inc.

Vera Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial Results

TRUTAKNA® (atacicept-vymj) U.S. launch building early momentum following July 7 accelerated approval by the U.S. Food and Drug Administration (FDA)…